Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2013 April;104(2) > Minerva Medica 2013 April;104(2):155-60

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  THROMBOSIS 

Minerva Medica 2013 April;104(2):155-60

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Myeloma and thrombotic complications

Tzoran I. 1, Brenner B. 1, 2, Hoffman R. 1, 2

1 Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus, Haifa, Israel; 2 Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel


PDF


Multiple myeloma (MM) is a hematological malignancy with high risk for thrombosis. While venous thromboembolism is more common, myeloma patients can also present with arterial thrombosis. Risk factors responsible for this complication can be patient-related, myeloma- and treatment-related. Thromboprophylaxis is indicated along with specific therapeutic regimens employed in myeloma patients. This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting.

top of page